Polyplus-transfection Database

Search for publications in the Transfection Database with Polyplus transfection reagents or for transfection conditions.

Over 4000 publications, 1000 cell lines and primary cells available.

Order by :  

Found 101 results :

Targeted Organin vitro
in vivo
Delivered MoleculeReagentResults & Citations
Tumorsin vivoDNA, siRNAin vivo-jetPEI
Francis, S. M., Taylor, C. A., Tang, T., Liu, Z., Zheng, Q., Dondero, R., Thompson, J. E. (2014)

Mol Ther 22, 1643-52
SNS01-T modulation of eIF5A inhibits B-cell cancer progression and synergizes with bortezomib and lenalidomide
More details
Tumorsin vivoDNAin vivo-jetPEI
Garg, H., Salcedo, R., Trinchieri, G., Blumenthal, R. (2010)

Cancer Gene Ther 17, 155-63
Improved nonviral cancer suicide gene therapy using survivin promoter-driven mutant Bax
More details
Tumorsin vivosiRNAin vivo-jetPEI
Gerster, K., Shi, W., Ng, B., Yue, S., Ito, E., Waldron, J., Gilbert, R., Liu, F. F. (2010)

Int J Radiat Oncol Biol Phys 77, 253-60
Targeting polo-like kinase 1 enhances radiation efficacy for head-and-neck squamous cell carcinoma
More details
Tumorsin vivosiRNAin vivo-jetPEI
Goodwin, C. R., Lal, B., Zhou, X., Ho, S., Xia, S., Taeger, A., Murray, J., Laterra, J. (2010)

Cancer Res 70, 2932-41
Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation
More details
Tumorsin vivoDNAin vivo-jetPEI
Hine, C. M., Seluanov, A., Gorbunova, V. (2012)

Mol Ther 20, 347-55
Rad51 promoter-targeted gene therapy is effective for in vivo visualization and treatment of cancer
More details
Tumorsin vivopre-miRNAin vivo-jetPEI
Hsu, C. Y., Hsieh, T. H., Tsai, C. F., Tsai, H. P., Chen, H. S., Chang, Y., Chuang, H. Y., Lee, J. N., Hsu, Y. L., Tsai, E. M. (2014)

J Pathol 232, 330-43
miRNA-199a-5p regulates VEGFA in endometrial mesenchymal stem cells and contributes to the pathogenesis of endometriosis
More details
Tumorsin vivooligonucleotide, shRNA oligonucleotidein vivo-jetPEI
Hu, G. H., Liu, H., Lai, P., Guo, Z. F., Xu, L., Yao, X. D., Zheng, J. H., Liu, M., Xu, Y. F. (2014)

Int J Clin Exp Pathol 7, 2143-52
Delta-like ligand 4 (Dll4) predicts the prognosis of clear cell renal cell carcinoma, and anti-Dll4 suppresses tumor growth in vivo
More details
Tumorsin vivoDNAin vivo-jetPEI
Hua, H., Wang, Y., Wan, C., Liu, Y., Zhu, B., Wang, X., Wang, Z., Ding, J. M. (2007)

Cancer Gene Ther 14, 815-8
Inhibition of tumorigenesis by intratumoral delivery of the circadian gene mPer2 in C57BL/6 mice
More details
Tumorsin vivosiRNAin vivo-jetPEI
Ito, T., Shimada, Y., Kan, T., David, S., Cheng, Y., Mori, Y., Agarwal, R., Paun, B., Jin, Z., Olaru, A., Hamilton, J. P., Yang, J., Abraham, J. M., Meltzer, S. J., Sato, F. (2008)

Cancer Res 68, 3214-24
Pituitary tumor-transforming 1 increases cell motility and promotes lymph node metastasis in esophageal squamous cell carcinoma
More details
Tumorsin vivoDNAin vivo-jetPEI
Kang, Y., Zhang, X., Jiang, W., Wu, C., Chen, C., Zheng, Y., Gu, J., Xu, C. (2009)

BMC Cancer 9, 126
Tumor-directed gene therapy in mice using a composite nonviral gene delivery system consisting of the piggyBac transposon and polyethylenimine
More details